Agilon Health Inc (NYSE:AGL) price closed higher on Friday, April 04, and jumping 3.75% above its previous close.
A look at the daily price movement shows that the last close reads $4.00, with intraday deals fluctuated between $3.89 and $4.31. The company’s 5Y monthly beta was ticking 0.388. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.73 and 52-week low of $1.50. The stock added 17.56% on its value in the past month.
Agilon Health Inc, which has a market valuation of $1.71 billion, is expected to release its quarterly earnings report on 2025-Feb-24.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give AGL a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 10 analysts have assigned AGL a recommendation rating as follows: 3 rate it as a Hold; 7 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Agilon Health Inc (AGL) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that AGL’s price is at present -1.39% off the SMA20 and 10.85% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 53.68, with weekly volatility standing at 7.58%. The indicator jumps to 7.14% when calculated based on the past 30 days. Agilon Health Inc (NYSE:AGL)’s beta value is holding at 0.41, while the average true range (ATR) indicator is currently reading 0.30. Considering analysts have assigned the stock a price target range of $2.5-$2.5 as the low and high respectively, we find the trailing 12-month average consensus price target to be $2.5. Based on this estimate, we see that current price is roughly 39.76% off the estimated low and 39.76% off the forecast high. Investors will no doubt be excited to see the share price rise to $2.5, which is the median consensus price, and at that level AGL would be 39.76% from current price.
An analysis of the Agilon Health Inc (NYSE:AGL) stock in terms of its daily trading volume indicates that the 3-month average is 5.64 million. However, this figure increases on the past 10-day timeline to an average of 3.73 million.
Current records show that the company has 412.19M in outstanding shares. The insiders’ percentage holdings are 26.43% of outstanding shares while the percentage share held by institutions stands at 71.62%. The stats also highlight that short interest as of 2025-03-14, stood at 18.56 million shares, which puts the short ratio at the time at 2.65. From this we can glean that short interest is 1777.00 of company’s current outstanding shares. Notably, we see that shares short in March rose slightly given the previous month’s figure stood at 18.5 million. But the 118.42% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
